Athira Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.09.24	Athira Shares Plunge After Phase 2/3 Fosgonimeton Trial For Alzheimer's Fails To Meet Endpoints (RTTNews)
15.04.24	Athira Pharma Appoints Javier San Martin As New Chief Medical Officer (RTTNews)
12.12.23	Athira Pharma Phase 2 SHAPE Study Of Fosgonimeton Fails (RTTNews)
22.05.23	Athira Pharma Names Andrew Gengos CFO - Quick Facts (RTTNews)
25.03.22	ETNB To Report ENTRIGUE Data In Q2, MDVL's Q1 Revenue To More Than Double, OCUP On Watch (RTTNews)
05.01.22	NUBIAN AND ATHENA ANNOUNCE CLOSING OF SALE AND ACQUISITION OF EXCELSIOR SPRINGS PROJECT (PR Newswire)
03.01.22	Can Athira's ACT Lift Its Share Price? (RTTNews)
21.08.21	FINAL NOTICE: Investors with Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit - ATHA (PR Newswire)
20.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA (PR Newswire)
19.08.21	DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Athira Pharma, Inc. Securities Fraud Class Action Lawsuit (PR Newswire)
14.08.21	ROSEN, A TOP RANKED LAW FIRM, Encourages Athira Pharma, Inc. Investors to Secure Counsel Before Important August 24 Deadline in Securities Class Action - ATHA (PR Newswire)
04.08.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA (PR Newswire)
29.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA (PR Newswire)
18.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA (PR Newswire)
14.07.21	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors (PR Newswire)
12.07.21	ATHA INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Athira Pharma, Inc. (PR Newswire)
10.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA (PR Newswire)
07.07.21	Athira Pharma Investor Alert: Goldman Scarlato & Penny Investor Rights Lawyers Evaluate Potential Individual, Non-Class Action Claims on Behalf of ATHA Investors (PR Newswire)
03.07.21	(ATHA) Deadline Alert: Investors With Losses Over $75,000 Interested in Being a Lead Plaintiff in Securities Fraud Class Action Lawsuit Against Athira Pharma - Contact Johnson Fistel (PR Newswire)
02.07.21	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA (PR Newswire)
01.07.21	ATHIRA PHARMA, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Weste... (PR Newswire)
30.06.21	ATHA INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Athira Pharma, Inc. (PR Newswire)
29.06.21	ATHA Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Athira Pharma, Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm (PR Newswire)
29.06.21	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Athira Pharma (ATHA) Investors to Contact Firm's Attorneys Now, Securities Fraud Case Filed (PR Newswire)
21.06.21	Ademi LLP Investigates Claims of Securities Fraud against Athira Pharma, Inc. (PR Newswire)
20.10.20	ABBV Seeks Expanded Approval Of Rinvoq, APTX Cheered By PTSD Data, ENDP Snaps Up BSTC, LQDA On Watch (RTTNews)
16.09.20	This Week's Healthcare IPOs (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Athira Pharma Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten